Paloma Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,834
| Closed | -$466K | – | 548 |
|
|
2024
Q3 | $466K | Buy |
6,834
+2,352
| +52% | +$133K | 0.01% | 647 |
|
|
2024
Q2 | $189K | Buy |
4,482
+4,466
| +27,913% | +$246K | 0.01% | 1007 |
|
|
2024
Q1 | $1.1K | Buy |
+16
| New | +$1.01K | ﹤0.01% | 738 |
|
|
2022
Q3 | – | Sell |
-31,600
| Closed | -$1.25M | – | 1119 |
|
|
2022
Q2 | $1.25M | Buy |
+31,600
| New | +$1.69M | 0.04% | 373 |
|
|
2022
Q1 | – | Sell |
-60,200
| Closed | -$4.68M | – | 1908 |
|
|
2021
Q4 | $4.68M | Buy |
+60,200
| New | +$5.31M | 0.07% | 235 |
|
|
2021
Q2 | – | Sell |
-2,662
| Closed | -$351K | – | 1908 |
|
|
2021
Q1 | $351K | Buy |
2,662
+1,681
| +171% | +$230K | 0.01% | 1379 |
|
|
2020
Q4 | $130K | Sell |
981
-38,779
| -98% | -$4.69M | ﹤0.01% | 1478 |
|
|
2020
Q3 | $4.05M | Sell |
39,760
-120,848
| -75% | -$10.4M | 0.1% | 187 |
|
|
2020
Q2 | $14M | Buy |
+160,608
| New | +$12.8M | 0.24% | 62 |
|
|
2020
Q1 | – | Sell |
-6,613
| Closed | -$612K | – | 1478 |
|
|
2019
Q4 | $612K | Sell |
6,613
-2,429
| -27% | -$214K | 0.01% | 1268 |
|
|
2019
Q3 | $817K | Buy |
+9,042
| New | +$1.03M | 0.02% | 854 |
|
|
2019
Q2 | – | Sell |
-4,502
| Closed | -$391K | – | 1867 |
|
|
2019
Q1 | $391K | Buy |
+4,502
| New | +$383K | 0.01% | 1192 |
|
|
2018
Q3 | – | Sell |
-348,435
| Closed | -$20.8M | – | 1651 |
|
|
2018
Q2 | $20.8M | Buy |
+348,435
| New | +$18.8M | 0.38% | 26 |
|
|
2018
Q1 | – | Sell |
-6,324
| Closed | -$332K | – | 2034 |
|
|
2017
Q4 | $332K | Buy |
+6,324
| New | +$338K | ﹤0.01% | 1499 |
|
|
2017
Q1 | – | Sell |
-18,300
| Closed | -$244K | – | 2032 |
|
|
2016
Q4 | $244K | Buy |
+18,300
| New | +$295K | ﹤0.01% | 1774 |
|
|
2015
Q4 | – | Sell |
-19,707
| Closed | -$354K | – | 1766 |
|
|
2015
Q3 | $354K | Buy |
+19,707
| New | +$453K | 0.01% | 1206 |
|
|
2015
Q2 | – | Sell |
-18,212
| Closed | -$401K | – | 1827 |
|
|
2015
Q1 | $401K | Buy |
+18,212
| New | +$462K | 0.01% | 867 |
|
|
2014
Q4 | – | Sell |
-15,800
| Closed | -$306K | – | 1205 |
|
|
2014
Q3 | $306K | Buy |
+15,800
| New | +$290K | 0.01% | 702 |
|
Other funds holding EXAS
Paloma Partners's EXAS Position: Q4 2024 in Review
Paloma Partners sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 6,834 shares — an estimated $466K sold.
Paloma Partners first reported a position in EXAS in Q3 2014 and held it in 18 quarters. The position peaked at $20.8M in Q2 2018. 592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.
- Paloma Partners reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
- Paloma Partners sold 6,834 Exact Sciences shares in Q4 2024, an estimated $466K.
- Paloma Partners first reported a position in Exact Sciences in Q3 2014 and held it in 18 quarters.
- Paloma Partners's Exact Sciences position peaked at $20.8M in Q2 2018.
- 592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.
Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.